Growth Metrics

Bionano Genomics (BNGO) Other Non-Current Assets (2020 - 2025)

Bionano Genomics (BNGO) has disclosed Other Non-Current Assets for 6 consecutive years, with $2.7 million as the latest value for Q4 2025.

  • Quarterly Other Non-Current Assets fell 2.18% to $2.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.7 million through Dec 2025, down 2.18% year-over-year, with the annual reading at $2.7 million for FY2025, 2.18% down from the prior year.
  • Other Non-Current Assets hit $2.7 million in Q4 2025 for Bionano Genomics, down from $2.8 million in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $11.4 million in Q2 2024 to a low of $235000.0 in Q1 2021.
  • Historically, Other Non-Current Assets has averaged $2.3 million across 5 years, with a median of $400000.0 in 2023.
  • Biggest YoY gain for Other Non-Current Assets was 2752.0% in 2024; the steepest drop was 62.94% in 2024.
  • Year by year, Other Non-Current Assets stood at $645000.0 in 2021, then soared by 274.26% to $2.4 million in 2022, then skyrocketed by 207.83% to $7.4 million in 2023, then crashed by 62.94% to $2.8 million in 2024, then dropped by 2.18% to $2.7 million in 2025.
  • Business Quant data shows Other Non-Current Assets for BNGO at $2.7 million in Q4 2025, $2.8 million in Q4 2024, and $400000.0 in Q3 2024.